Inhibrxの営業利益
Inhibrxの営業利益は何ですか。
Inhibrx, Inc.の営業利益は-19,904.96%です。
営業利益の定義は何ですか。
営業利益率は、営業利益を純売上高で除したもので、パーセントで表しています。
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
NASDAQのセクタHealth Careにおける営業利益の企業と比べるInhibrx
Inhibrxは何をしますか。
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.
Inhibrxと類似の営業利益
- Pluri Incの営業利益は-20,212.82%です。
- Ookamiの営業利益は-20,088.76%です。
- Crinetics Pharmaceuticals Incの営業利益は-20,068.38%です。
- Roto-Gro Internationalの営業利益は-20,044.77%です。
- Chant Westの営業利益は-20,038.78%です。
- Tamaska Oil and Gasの営業利益は-20,020.00%です。
- Inhibrxの営業利益は-19,904.96%です。
- American Pacific Boratesの営業利益は-19,860.79%です。
- Techgen Metals Ltdの営業利益は-19,765.76%です。
- Buderimの営業利益は-19,640.00%です。
- Organovo Incの営業利益は-19,557.53%です。
- Cardinal Resourcesの営業利益は-19,237.68%です。
- Celsius Resourcesの営業利益は-18,949.52%です。